In addition, MAGED2 is able to suppress the expression of TRAIL death receptor 2 (TRAIL-R2) and plays an important role in protecting melanoma cells from apoptosis induced by TRAIL (19), thus it has been recognized as a cancer diagnostic marker (52). Here, TNFRSF10B is linked to cancer.